(Q70274739)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3079699%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

title

Tissue-type plasminogen activator. Therapeutic potential in thrombotic disease states (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3079699%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

D Collen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3079699%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3079699%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3079699%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3079699%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3079699%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

page(s)

1-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3079699%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-198631010-00001

10 October 2019

exact match

0 references

cites work

Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator

1 reference

12 December 2020

On the Kinetics of the Reaction between Human Antiplasmin and Plasmin

1 reference

12 December 2020

Purification and partial characterization of plasminogen activator from human uterine tissue

1 reference

12 December 2020

Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates

1 reference

12 December 2020

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

1 reference

12 December 2020

Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin

1 reference

12 December 2020

Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus

1 reference

12 December 2020

Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology

1 reference

12 December 2020

Clot-selective coronary thrombolysis with tissue-type plasminogen activator

1 reference

12 December 2020

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration

1 reference

12 December 2020

Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator

1 reference

12 December 2020

Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator

1 reference

12 December 2020

Coronary thrombolysis with recombinant human tissue-type plasminogen activator

1 reference

12 December 2020

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis

1 reference

12 December 2020

Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells

1 reference

12 December 2020

On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture

1 reference

12 December 2020

A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.

1 reference

12 December 2020

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

1 reference

12 December 2020

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

12 December 2020

Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture

1 reference

12 December 2020

Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo

1 reference

12 December 2020

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

1 reference

12 December 2020

Tissue activators of plasminogen

1 reference

12 December 2020

Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction

1 reference

12 December 2020